Wayne Pisano - 12 Feb 2026 Form 4 Insider Report for ONCOLYTICS BIOTECH INC (ONCY)

Reporting relationship: Director
Issuer ticker: ONCY
Reported as of: 12 Feb 2026
Net transaction value: +$25,338
SEC form: 4
Accepted by SEC: 13 Feb 2026, 07:00:29 UTC
Prior SEC filing: 09 Jan 2026
Next SEC filing: 01 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Kirk Look, Attorney-in-Fact

Key filing fact

Wayne Pisano filed Form 4 for ONCOLYTICS BIOTECH INC (ONCY) on 13 Feb 2026.

Key facts

This page summarizes Wayne Pisano's Form 4 filing for ONCOLYTICS BIOTECH INC (ONCY).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 13 Feb 2026, 07:00.

Change

Previous filing in this sequence was filed on 09 Jan 2026.
Current net transaction value: +$25,338.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001743611 Primary reporting owner

Pisano Wayne

Relationship: Director
Address: C/O ONCOLYTICS BIOTECH INC., 4350 EXECUTIVE DRIVE, SUITE 325, SAN DIEGO
Signature: /s/ Kirk Look, Attorney-in-Fact
Signature date: 13 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ONCY transaction

Common Shares

Purchase

Transaction value: $25,338
Shares: +30,000
Change %: +6.5%
Price: $0.8446
Shares after: 492,414
Date: 12 Feb 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.83 to $0.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.